Confirming the documented effect of hyperglycemia on AT1 receptor expression [24, 27, 50], STZ treatment in the present study was paralleled by alterations in the pattern of AT1 receptor expression in both renal and hepatic tissues. This evidence concerns the gene AGTR1 and Hyperglycemia.